|
|
|
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
|
FOR IMMEDIATE RELEASE |
Media Inquiries: 301-827-6242 |
The Institute of Medicine (IOM), a leading organization that advises the United States government on the most critical issues in medicine and public health, today announced its election of Mark B. McClellan, M.D., Ph.D., and Lester M. Crawford, D.V.M., Ph.D., respectively the Commissioner and Deputy Commissioner of the Food and Drug Administration, as members of the institute. The highly prestigious IOM, a non-profit component of the National Academy of Sciences, has elected individual FDA scientists in the past, but never both the Commissioner and the Deputy Commissioner.
"I applaud Mark and Les for receiving this honor," said Tommy G. Thompson, Secretary of the Department of Health and Human Services. "Every day at the FDA, they show real leadership in developing and implementing creative new ways to better protect and promote the health of Americans. The Institute of Medicine will benefit from their experience and expertise in science and public health."
New IOM members are chosen world-wide on the basis of their distinguished professional achievement in a field related to medicine and health, and on their involvement in health care, disease prevention, education and research. They contribute to IOM's reports and research projects without pay.
"Both Les and I are honored to become IOM members, and we will do our part to support the IOM's unique public health mission," Dr. McClellan commented on the IOM announcement. "And at FDA, we're pleased to be part of an organization that is recognized around the world for using the best and latest science to protect and advance the health of the public."
####